Correlation Between Forte Biosciences and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Forte Biosciences and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Forte Biosciences and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Forte Biosciences and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Forte Biosciences and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Forte Biosciences with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Forte Biosciences and Pasithea Therapeutics.
Diversification Opportunities for Forte Biosciences and Pasithea Therapeutics
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Forte and Pasithea is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Forte Biosciences and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Forte Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Forte Biosciences are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Forte Biosciences i.e., Forte Biosciences and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Forte Biosciences and Pasithea Therapeutics
Given the investment horizon of 90 days Forte Biosciences is expected to generate 1.27 times more return on investment than Pasithea Therapeutics. However, Forte Biosciences is 1.27 times more volatile than Pasithea Therapeutics Corp. It trades about 0.05 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.01 per unit of risk. If you would invest 1,185 in Forte Biosciences on August 26, 2024 and sell it today you would earn a total of 415.00 from holding Forte Biosciences or generate 35.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.6% |
| Values | Daily Returns |
Forte Biosciences vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Forte Biosciences |
| Pasithea Therapeutics |
Forte Biosciences and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Forte Biosciences and Pasithea Therapeutics
The main advantage of trading using opposite Forte Biosciences and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Forte Biosciences position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| Forte Biosciences vs. Eliem Therapeutics | Forte Biosciences vs. HCW Biologics | Forte Biosciences vs. Scpharmaceuticals | Forte Biosciences vs. Milestone Pharmaceuticals |
| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Virax Biolabs Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |